US4407943A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immobilized antibody or antigen for immunoassay
Assignee: EMD Millipore Corp
•
Filing: 1980-03-13
•
Granted: 1983-10-04
•
Expires: 2000-03-13
Abstract
Abstract An antigen or antibody and an immunochemically neutral protein are immobilized in two stages on a microporous membrane coated with a protein such as zein or collagen. Immobilized antigen to Toxoplasma gondii is used in an immunoassay to detect the presence of antibody to Toxoplasma gondii in serum. Antibody that becomes bound to the immobilized antigen is detected with an antibody- enzyme conjugate. Immobilizing the immunochemically netural protein on the membrane in a second stage immobilization step minimizes nonspecific binding during the immunoassay.
Inventors
- 👤 Francis X. Cole
- 👤 Deborah M. Van Voorhis
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 12:58
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54366; G01N33/569; G01N33/56905; Y; Y10; Y10S; Y10S435/00; Y10S435/962; Y10S435/964; Y10S435/975; Y10S436/00; Y10S436/807; Y10S436/809; Y10S436/811
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
156 words
A method of nonimmunochemically immobilizing two proteins on the internal and external surfaces of a microporous membrane having pore sizes in the range from 25 nanometers to 25 micrometers in its uncoated state, comprising: coating the internal and external surfaces of the membrane with a protein selected from the group consisting of zein and collagen, to provide a coated membrane that is at least 50% microporous, immersing the coated membrane in a solution of a biologically active first protein selected from the group consisting of the antigen of and the antibody to Toxoplasma gondii, in order to immobilize the first protein, then immersing the coated membrane having the biologically active first protein immobilized thereon in a solution of an immunochemically neutral second protein selected from the group consisting of fetal calf serum and bovine gamma globulin fraction II, in order to immobilize the second protein while the first protein remains immobilized and retains its biological activity.
Claim 2
Independent Claim
156 words
A method of nonimmunochemically immobilizing two proteins on the internal and external surfaces of a microporous membrane having pore sizes in the range from 25 nanometers to 25 micrometers in its uncoated state, comprising: coating the internal and external surfaces of the membrane with a protein selected from the group consisting of zein and collagen, to provide a coated membrane that is at least 50% microporous, immersing the coated membrane in a solution of a biologically active first protein selected from the group consisting of the antigen of and the antibody to Toxoplasma gondii, in order to immobilize the first protein, then immersing the coated membrane having the biologically active first protein immobilized thereon in a solution of an immunochemically neutral second protein selected from the group consisting of fetal calf serum and bovine gamma globulin fraction II, in order to immobilize the second protein while the first protein remains immobilized and retains its biological activity.
Claim 3
Dependent Claim
15 words
A method in accordance with claim 1 wherein the first immobilized protein is an antigen.
Claim 4
Dependent Claim
15 words
A method in accordance with claim 1 wherein the first immobilized protein is an antibody.
Claim 5
Dependent Claim
210 words
In an immunochemical assay for detecting the presence in a solution of an immunochemical component selected from the group consisting of the antigen of and the antibody to Toxoplasma gondii, comprising a specific binding reaction between a first immunochemical component selected from the group consisting of said antigen and said antibody immobilized on the coated surfaces of a microporous membrane having pore sizes in the range from 25 nanometers to 25 micrometers in its uncoated state, and that is at least 50% microporous, and a second component selected from the group consisting of the antigen of and the antibody to Toxoplasma gondii that binds with the first immunochemical component in a test fluid, wherein nonspecific binding occurs as a side reaction and wherein the coating is a protein selected rom the group consisting of zein and collagen, a method for suppressing the nonspecific binding comprising: treating the coated membrane, having the first component immobilized thereon, by immobilizing on the coated membrane a protein immunochemically neutral in the assay and selected from the group consisting of fetal calf serum and bovine gamma globulin fraction II, whereby when the second component is brought into reactive proximity to the immobilized first component, a specific immunochemical reaction takes place and nonspecific binding is suppressed.
Claim 6
Dependent Claim
210 words
In an immunochemical assay for detecting the presence in a solution of an immunochemical component selected from the group consisting of the antigen of and the antibody to Toxoplasma gondii, comprising a specific binding reaction between a first immunochemical component selected from the group consisting of said antigen and said antibody immobilized on the coated surfaces of a microporous membrane having pore sizes in the range from 25 nanometers to 25 micrometers in its uncoated state, and that is at least 50% microporous, and a second component selected from the group consisting of the antigen of and the antibody to Toxoplasma gondii that binds with the first immunochemical component in a test fluid, wherein nonspecific binding occurs as a side reaction and wherein the coating is a protein selected rom the group consisting of zein and collagen, a method for suppressing the nonspecific binding comprising: treating the coated membrane, having the first component immobilized thereon, by immobilizing on the coated membrane a protein immunochemically neutral in the assay and selected from the group consisting of fetal calf serum and bovine gamma globulin fraction II, whereby when the second component is brought into reactive proximity to the immobilized first component, a specific immunochemical reaction takes place and nonspecific binding is suppressed.
Claim 7
Dependent Claim
21 words
A method in accordance with claim 4 wherein the first component is an antibody and the second component is an antigen.
Claim 8
Dependent Claim
21 words
A method in accordance with claim 4 wherein the first component is an antitigen and the second component is an antibody.
References Cited (Backward Citations)
US3839153A
Cited
US3770380A
Cited
US4039652A
Cited
US4066512A
Cited
US4002532A
Cited
US3951748A
Cited
US4036946A
Cited
US4111754A
Cited
US4200690A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-10-03 | 1987-04-04 | 1987-10-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-10-03 | 1991-04-04 | 1991-10-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-10-03 | 1995-04-04 | 1995-10-04 | $7700.00 | Window Closed / Lapsed |